About us

Clisomo Nigeria Limited is a chemical manufacturing and distribution company. We specialized in the manufacture of various types of synthetic resins utilizing petro-chemical polymeric raw materials. At Clisomo we are proud of the strides that we have made since our founding in 2010 and incorporated in 2020, providing R&D and one-stop production services to the major Africa pharmaceutical companies. Our commitment to continuous optimization and investing in the future is the key to our success. We’ve built a knowledge and experience base that we’re eager to share by improving the capabilities our partners require now while maintaining the agility required to support innovation. Clisomo has distinguished itself in the manufacturing of high quality products and the delivery of excellent services since its inception, earning her widespread market recognition and patronage around the world. Whether aiding fledgling biotech firms or smaller ones, our objective remains the same: to accelerate the launch of innovative pharmaceuticals by offering one-stop CMC services throughout the full drug development lifecycle. Our services vary from early clinical to commercial phases, and include R&D and cGMP manufacture of advanced intermediates, APIs, formulations, and clinical research services.

We’ve built an integrated service ecosystem through smart alliances and measured business expansion.

Clisomo Nigeria Limited provides access to small molecule knowledge in the following areas at a minimal cost:

  • Organ metallic chemistry
  • Peptide synthesis
  • Heterocyclic chemistry
  • Mutli-step synthesis
  • Glycosidation reactions
  • Carbon-hetero atom bond formation
  • Carbon-carbon bond forming reactions
  • Functional group manipulations (such as Oxidations Reductions, Masked synthons for chemical reactivity)

Our Vision

Our Vision is to be the most reputable African chemical manufacturing and distribution company and energy solutions brand committed to driving the continent’s growth and transformation motivates us to be positively intentional in our interactions with stakeholders, particularly our employees.